PGR and neoplasm: Individual protein abundances of ER, PR, and HER2 did not fully agree with immunohistochemical assessment of the tumor, with notable discrepancies found for ER in tumors that were immunohistochemically scored with negative PR expression, a marker for an active ER (Supporting Information Fig. 4).